<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=1cP-AL-LAD</id>
	<title>1cP-AL-LAD - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=1cP-AL-LAD"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=1cP-AL-LAD&amp;action=history"/>
	<updated>2026-07-19T04:56:26Z</updated>
	<subtitle>本wiki上该页面的版本历史</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=1cP-AL-LAD&amp;diff=4522919&amp;oldid=prev</id>
		<title>imported&gt;Comrade John：​添加參數</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=1cP-AL-LAD&amp;diff=4522919&amp;oldid=prev"/>
		<updated>2026-03-22T05:06:52Z</updated>

		<summary type="html">&lt;p&gt;添加參數&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Drugbox&lt;br /&gt;
| IUPAC_name = (6aR,9R)-4-(cyclopropanecarbonyl)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide&lt;br /&gt;
| image = 1CP-AL-LAD_structure.png&lt;br /&gt;
| width = 200&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| legal_AU =  &lt;br /&gt;
| legal_CA =  &lt;br /&gt;
| legal_UK =  &lt;br /&gt;
| legal_US =&lt;br /&gt;
| legal_US_comment = &lt;br /&gt;
| routes_of_administration = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number = None&lt;br /&gt;
| PubChem = 162368406&lt;br /&gt;
| ChemSpiderID = None&lt;br /&gt;
| UNII = HH7F72QLZ3&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=26 | H=31 | N=3 | O=2 &lt;br /&gt;
| smiles = CCN(CC)C(=O)[C@@H]1C=C2[C@@H](Cc3cn(C(=O)C4CC4)c4cccc2c34)N(C1)CC=C&lt;br /&gt;
| StdInChI = 1S/C26H31N3O2/c1-4-12-28-15-19(25(30)27(5-2)6-3)13-21-20-8-7-9-22-24(20)18(14-23(21)28)16-29(22)26(31)17-10-11-17/h4,7-9,13,16-17,19,23H,1,5-6,10-12,14-15H2,2-3H3/t19-,23-/m1/s1&lt;br /&gt;
| StdInChIKey = VSABTUDYQCMWKE-AUSIDOKSSA-N&lt;br /&gt;
}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;{{PAGENAME}}&amp;#039;&amp;#039;&amp;#039;（1-cyclopropylmethanoyl-6-allyl-6-&amp;#039;&amp;#039;nor&amp;#039;&amp;#039;-LSD，1-环丙酰基-6-烯丙基-6-去甲-LSD）是一种[[有机化合物]]，化学式为[[C26H31N3O2|C&amp;lt;sub&amp;gt;26&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;31&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;3&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;]]，为[[迷幻药物]][[麥角酸二乙酰胺]]（LSD）的[[衍生物]]和[[AL-LAD]]（6-烯丙基-6-去甲-LSD）的[[前药]]，2021年6月在法国[[策划药]]黑市上发现&amp;lt;ref&amp;gt;{{Cite journal | vauthors = Morais J, Evans-Brown M, Gallegos A, Christie R, Jorge R, Planchuelo G, Sedefov R |date=2022-09-01 |title=New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System |url=https://www.sciencedirect.com/science/article/pii/S2352007822000944 |journal=Toxicologie Analytique et Clinique |series=30th meeting of SFTA- 59th meeting of TIAFT - September 2022 |volume=34 |issue=3, Supplement |pages=S29–S30 |doi=10.1016/j.toxac.2022.06.022 |issn=2352-0078}}&amp;lt;/ref&amp;gt;。&lt;br /&gt;
&lt;br /&gt;
==参考文献==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
==外部链接==&lt;br /&gt;
&lt;br /&gt;
[[Category:策划药]]&lt;br /&gt;
[[Category:麦角酰胺]]&lt;br /&gt;
[[Category:环丙基化合物]]&lt;br /&gt;
[[Category:羧酰胺]]&lt;br /&gt;
{{chem-stub}}&lt;/div&gt;</summary>
		<author><name>imported&gt;Comrade John</name></author>
	</entry>
</feed>